RLMD Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-14SCHEDULE 13G/A0002050709-26-000025SEC →
2026-08-068-K0001213900-26-086190SEC →
2026-08-0610-Q0001213900-26-086151SEC →
2026-07-29SCHEDULE 13G0002012383-26-002872SEC →
2026-07-288-K0001213900-26-082007SEC →
2026-06-22SCHEDULE 13G0001104659-26-076490SEC →
2026-06-18S-80001213900-26-070097SEC →
2026-06-09SCHEDULE 13G0001738048-26-000066SEC →
2026-05-288-K0001213900-26-062184SEC →
2026-05-13S-3ASR0001213900-26-055901SEC →
2026-05-13SCHEDULE 13G/A0000919574-26-002929SEC →
2026-05-128-K0001213900-26-055164SEC →
2026-05-1210-Q0001213900-26-055059SEC →
2026-05-04SCHEDULE 13G0001831942-26-000017SEC →
2026-04-17DEFA14A0001213900-26-045194SEC →
2026-04-17DEF 14A0001213900-26-045192SEC →
2026-04-09EFFECT9999999995-26-001136SEC →
2026-04-09424B30001213900-26-042007SEC →
2026-04-07CORRESP0001213900-26-040821SEC →
2026-04-07UPLOAD0000000000-26-003470SEC →
2026-04-06PRE 14A0001213900-26-040498SEC →
2026-04-03S-30001213900-26-039967SEC →
2026-03-208-K0001213900-26-032403SEC →
2026-03-1910-K0001213900-26-031862SEC →
2026-03-098-K0001213900-26-024918SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Relmada Therapeutics (RLMD) — Filings